These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25151935)

  • 1. [Rosacea - dermocosmetic management: skin-care and corrective make-up].
    Deshayes P
    Ann Dermatol Venereol; 2014 Sep; 141 Suppl 2():S179-83. PubMed ID: 25151935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermocosmetic management of the red face and rosacea.
    Guerrero D
    Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S215-8. PubMed ID: 22183102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A.
    Weber TM; Ceilley RI; Buerger A; Kolbe L; Trookman NS; Rizer RL; Schoelermann A
    J Cosmet Dermatol; 2006 Sep; 5(3):227-32. PubMed ID: 17177744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM; Weber TM; Arrowitz C; Rizer RL; Qian K; Babcock M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea.
    Jovanovic Z; Angabini N; Ehlen S; Mokos ZB; Subotic M; Neufang G
    J Drugs Dermatol; 2017 Jun; 16(6):605-610. PubMed ID: 28686779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dermocosmetic management of the red face and rosacea].
    Guerrero D
    Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S163-6. PubMed ID: 21907877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care.
    Del Rosso JQ; Thiboutot D; Gallo R; Webster G; Tanghetti E; Eichenfield L; Stein-Gold L; Berson D; Zaenglein A
    Cutis; 2013 Nov; 92(5):234-40. PubMed ID: 24343208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive cleansing: an underestimating risk factor of rosacea in Chinese population.
    Li G; Wang B; Zhao Z; Shi W; Jian D; Xie H; Huang Y; Li J
    Arch Dermatol Res; 2021 May; 313(4):225-234. PubMed ID: 32594335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmetics in acne and rosacea.
    Draelos ZD
    Semin Cutan Med Surg; 2001 Sep; 20(3):209-14. PubMed ID: 11594677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants.
    Del Rosso JQ
    Cutis; 2005 Mar; 75(3 Suppl):17-21; discussion 33-6. PubMed ID: 15810806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of quality of life after a medical corrective make-up lesson in patients with various dermatoses.
    Peuvrel L; Quéreux G; Brocard A; Saint-Jean M; Vallet C; Mère A; Labetoulle G; Le Fol C; Dréno B
    Dermatology; 2012; 224(4):374-80. PubMed ID: 22759904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating beyond the histology of rosacea.
    Draelos ZD
    Cutis; 2004 Sep; 74(3 Suppl):28-31, 32-4. PubMed ID: 15499756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard management options for rosacea, part 1: overview and broad spectrum of care.
    Odom R; Dahl M; Dover J; Draelos Z; Drake L; Macsai M; Powell F; Thiboutot D; Webster GF; Wilkin J;
    Cutis; 2009 Jul; 84(1):43-7. PubMed ID: 19743724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rosacea with intense pulsed light.
    Taub AF
    J Drugs Dermatol; 2003 Jun; 2(3):254-9. PubMed ID: 12848109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermocosmetics for Use in Rosacea: Guideline of the Society for Dermopharmacy.
    Kresken J; Kindl U; Wigger-Alberti W; Clanner-Engelshofen BM; Reinholz M
    Skin Pharmacol Physiol; 2018; 31(3):147-154. PubMed ID: 29597196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea.
    Draelos ZD
    Cutis; 2006 Apr; 77(4 Suppl):27-33. PubMed ID: 16706247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD; Colón LE; Preston N; Johnson LA; Gottschalk RW
    Cutis; 2011 May; 87(5):251-9. PubMed ID: 21699130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for vascular pathogenic mechanisms in rosacea: implications for patient care.
    Wilkin J
    Cutis; 2008 Aug; 82(2):100-2. PubMed ID: 18792539
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of skin care habits on the development of rosacea: A multi-center retrospective case-control survey in Chinese population.
    Huang YX; Li J; Zhao ZX; Zheng BL; Deng YX; Shi W; Steinhoff M; Xie HF
    PLoS One; 2020; 15(4):e0231078. PubMed ID: 32339170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-Induced Rosacea-like Dermatitis.
    Rezaković S; Bukvić Mokos Z; Paštar Z
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):49-54. PubMed ID: 27149131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.